Teva to Present at the UBS Global Healthcare Conference
15 Mai 2014 - 2:00PM
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live
audio webcast at the UBS Global Healthcare Conference. Eyal Desheh,
EVP & CFO will present on Monday, May 19, 2014 at 1:00 PM
ET.
What: Teva Presentation at the UBS Global Healthcare
Conference
Who: Eyal Desheh, EVP and CFO,
Teva Pharmaceutical Industries Ltd.
When: Monday, May 19, 2014
Where: www.tevapharm.com
How: Live over the Internet – log on to the Web at the
address above and register for the event (approximately 10 minutes
before). An archive of the webcast will be available on Teva’s
website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading
global pharmaceutical company, committed to increasing access to
high-quality healthcare by developing, producing and marketing
affordable generic drugs as well as innovative and specialty
pharmaceuticals and active pharmaceutical ingredients.
Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules
and a direct presence in approximately 60 countries. Teva's
Specialty Medicines businesses focus on CNS, respiratory oncology,
pain, and women's health therapeutic areas as well as biologics.
Teva currently employs approximately 45,000 people around the world
and reached $20.3 billion in net revenues in 2013.
Teva Pharmaceutical Industries Ltd.IR:United StatesKevin C.
Mannix, 215-591-8912orRan Meir,
215-591-3033orIsraelTomer Amitai, 972 (3)
926-7656orPR:IsraelIris Beck Codner, 972 (3)
926-7246orUnited StatesDenise Bradley, 215-591-8974
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024